Evidence-Based Practice for Asthma Patients

1
Running head: EVIDENCE- BASED PRACTICE FOR ASTHMA PATIENTS
Evidence- Based Practice for Asthma Patients
Name
Institution

2
EVIDENCE- BASED PRACTICE FOR ASTHMA PATIENTS
Evidence- Based Practice for Asthma Patients
Evidence-based practice is the incorporation of the patients’ needs, best clinical research
available and clinical experience which brings out the best outcomes from the patient (Parrish,
2018). It stands as a collective name for sub-branches which include; evidence-based dentistry,
evidence-based medicine, evidence-based public health, evidence-based nursing and may more.
This kind of practice in medicine gained its name in the 1990s where David Sackett and his
associates researched about it. It is a kind of practice in medicine that is dependent on evidence
and research.
It is based on two principles and that is; pursuing the highest degree of evidence
and skill and patient’s values. Pursuing the highest level of evidence available should be done
using an evidence-based practice process to get the right results (Rice, 2011). Whenever there is
a need to describe an intervention where science is not fully applicable, the second principle of
EBP should be applied. The second principle encompasses matching the values of the patient and
the clinical skill available (Rice, 2011).
Asthma is a lung infection that is normally characterized by coughing, wheezing and lack
of breath. It affects all age groups but is more prevalent with children. It costs the Australian
government 1.2 billion dollars annually to treat and manage asthma (Australian Bureau of
Statistics, 2018). Between 2012 and 2014, it killed about one thousand people and according to
the chief executive of Asthma Australia, the deaths could have been prevented. These deaths
could be prevented and the money used for treatment could be used to improve infrastructure in
the country and therefore a better way should be found to deal with asthma.

3
EVIDENCE- BASED PRACTICE FOR ASTHMA PATIENTS
Can management and quality learning of nurses using intravenous magnetic sulfate
reduce the infection of asthma in children? Asthma is known to attack children more than adults
and stays with them until when they are adults. If asthma can be treated when children are still
young, they will grow up with high chances of survival. This research needs to be done so that
less few people will have attacks of asthma, less money will be channeled to treat asthma and
there will be fewer deaths related to asthma. Population or the problem in this question is
infections of asthma in children, intervention is using intravenous magnesium sulfate, the
comparison is the usage of antibiotics and intravenous beta-agonists, and outcome of interest is
the reduction of the effects of infection in childhood years. The key search terms will include
names such as antibiotics, asthma and intravenous magnesium sulfate.
In Therapeutic uses of magnesium (2009), Guerrera cites that magnesium is applicable to
patients suffering from severe acute asthma. Intravenous and nebulized magnesium sulfate for
treating acute asthma in adults and children: a systematic review and meta-analysis (2013)
presents a conclusion that intravenous magnesium sulfate with the addition of beta 2 agonists
reduced the number of children being hospitalized due to asthma. In research done by
Ingemansson, Evidence-based practice for children with asthma in primary care: quality of
management and effects of learning, it was found that more guidelines were required for there to
be fewer infections of asthma in children.
Asthma has affected children in Australia and has been cited to be one of the few
countries that rate the highest number in the world. At a young age, more boys are affected with
asthma than girls and at the age of fifteen years and above, the ladies are the ones who are
affected more (National Health Survey, 2018). Causes of asthma in children include; a mother
who used to smoke during pregnancy, obesity and family members with sicknesses such as hay